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OVERVIEW ON ASSOCIATION OF DIFFERENT TYPES 
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Exposure to ionizing radiation is associated with increasing risk of various types of hematological malignancies. The results of ma-
jor studies on association of leukemias and radiation exposure of large populations in Japan and in Ukraine are analyzed. The pat-
terns of different types of leukemia in 295 Chernobyl clean-up workers diagnosed according to the criteria of up-to-date World 
Health Organization classification within 10–25 years following Chernobyl catastrophe are summarized. In fact, a broad spectrum 
of radiation-related hematological malignancies has been revealed both in Life Span Study in Japan and in study of Chernobyl 
clean-up workers in Ukraine. The importance of the precise diagnosis of tumors of hematopoietic and lymphoid tissues according 
to up-to-date classifications for elucidating the role of radiation as a causative factor of leukemias is emphasized. Such studies are 
of high importance since according to the recent findings, radiation-associated excess risks of several types of leukemias seem 
to persist throughout the follow-up period up to 55 years after the radiation exposure.
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RISK OF LEUKEMIA FOLLOWING 
RADIATION EXPOSURE: BACKGROUND 
INFORMATION
Increasing risk of leukemia and cancer is believed 
to represent the most serious late effect of the expo-
sure to ionizing radiation. The risks of hematological 
malignancies related to the acute or protracted low 
dose or low dose rate of radiation exposure in various 
populations have been assessed in several studies. 
In particular, the risks of leukemias and other types 
of hematological malignancies in A-bomb survivors 
have been the subject of on-going studies conducted 
at Radiation Effects Research Foundation (RERF), 
Research Institute for Nuclear Medicine and Biology 
Hiroshima University, and Atomic Bomb Disease In-
stitute Nagasaki University School of Medicine [1–3]. 
In fact, leukemia was the first malignancy linked to ra-
diation exposure in atomic bomb survivors. Much has 
been learned about leukemia incidence and mortality 
in RERF Life Span Study (LSS) cohort of A-bomb survi-
vors [1, 3]. The results of several studies on association 
between leukemia and radiation exposure in Chernobyl 
clean-up workers and population of contaminated 
areas have been also presented [4, 5].
The relative leukemia risk has been shown to in-
crease directly proportional to the bone marrow dose. 
For leukemia cases diagnosed in Japan, this relationship 
was particularly striking for chronic myeloid leukemia 
(CML) and acute lymphoblastic leukemia (ALL) indica-
ting the close association between ionizing radiation and 
the induction of these types of leukemia. The association 
between radiation exposure and acute myeloblastic 
leukemia (AML) has been also proved [1, 6].
Excess relative risk (ERR) per unit of radiation for 
leukemia appears to be one of the highest among all ra-
diation-associated cancers [7]. However, the absolute 
number of leukemia cases even in such large cohorts 
as A-bomb survivors and Chernobyl clean-up workers 
is low because leukemia incidence is much lower than 
that of the most prevalent solid cancers (leukemia ac-
counts for only 4% of all cancer deaths in LSS).
The patterns of radiation exposure of human popu-
lations including the mode of radiation, the contribu-
tion of internal versus external radiation, the cumulative 
dose and dose rate, etc. varied significantly. Neverthe-
less, the total relative risk assessments of leukemias 
in Japanese atomic bomb survivors [3] and in oc-
cupationally exposed nuclear industry workers [8] 
seemed to be within the same order of magnitude. 
The ERR of 4.9 per 1 Gy was assessed in the general 
populations living in Ural area contaminated with radio-
nuclides [9]. Moreover, 32–48% of all leukemia cases 
in these studies were estimated as attributable to ra-
diation exposure [3, 9]. In Russian cohort of Chernobyl 
clean-up workers, Ivanov et al. [10] demonstrated 
the time-averaged ERR per 1 Gy for leukemias slightly 
exceeding that in LSS cohort in Japan.
The excess radiation-induced leukemias should 
be evident in about two years after radiation exposure 
with excess peak at about 7–8 years after exposure. 
In fact, the systematic analysis of leukemia incidence 
and mortality in Hiroshima and Nagasaki was launched 
in 5 years following A-bombing, so a significant num-
ber of early cases was probably missed. The same 
holds true for leukemia study in Chernobyl clean-
up workers and other categories of people suffered 
after Chernobyl since the collection of data and their 
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systematical analysis has not started earlier than 
in several years following the catastrophe. Moreover, 
according to the recent data based on long-term study 
of the consequences of exposure to ionizing radiation 
in LSS, radiation-associated excess risks are recog-
nized as persisting throughout the follow-up period 
up to 55 years after the exposure (and may be even 
longer) [3, 11]. Even after 45–55 years after exposure, 
the radiation-associated leukemia risk at 1 Gy was esti-
mated to be twice the baseline risk [3]. This conclusion 
is of paramount importance for the follow-up of he-
matological malignancies in a cohort of Chernobyl 
clean-up workers.
In general, the incidence of radiation-associated 
leukemias increased with decreasing age at the time 
of A-bombing. LSS has also demonstrated that the risk 
associated with radiation exposure as well as shapes 
of the dose-response curves and the effects of age 
and gender varied significantly among the major types 
of leukemia proved as radiation-induced, namely 
CML, ALL and AML [6]. For ALL, risk appeared higher 
for childhood exposures and declined over time. For 
CML risk also declined over the time but the age 
at exposure was not found to have a significant ef-
fect on risk. The dose-response pattern for AML was 
less dependent on age at exposure or time since 
exposure as compared with ALL or CML. Moreover, 
contrary to ALL and CML, the excess rates for AML 
seem to rise with increasing attained age for those 
exposed as adults [3].
According to retrospective study, the explosion 
of A-bomb also led to an increased incidence of my-
elodysplastic syndromes (MDS), which occurred later 
than AML. The increasing rates of leukemias and MDS 
in Hiroshima and Nagasaki correlated with dose levels 
within 0.1–0.5 Gy based on the latest revision of do-
simetry system [12, 13].
FINDINGS, ESTIMATIONS 
AND PREDICTIONS MADE BY VARIOUS 
RESEARCH TEAMS ON LEUKEMIA 
AND LYMPHOMA INCIDENCE 
IN CHERNOBYL CLEAN-UP WORKERS
A cohort of Chernobyl clean-up workers of 1986–
1987 provides another large massive of data accessible 
for the analysis of association between leukemias and 
the exposure to ionizing radiation. In total, more than 
2.3 million people in Ukraine are included to the State 
Registry of Ukraine for people who suffered due 
to Chernobyl disaster (as of January 1, 2011); among 
them, more than 260 thousand clean-up workers are 
registered including more than 155 thousand people 
participating in emergency works in 1986. In Russia, 
196 thousand clean-up workers are included into cor-
responding Registry.
Several research teams in Russia, Belarus and 
Ukraine as well as the multinational research teams 
have presented different estimates as to leukemia and 
lymphoma incidence in Chernobyl clean-up workers. 
Sometimes, however, the overall leukemia incidence 
in the exposed persons was taken into consideration 
without subdivision to the major biological types 
of the diseases. In most of the studies, only the major 
groups of leukemias such as AML, ALL (or even acute 
leukemias in total), and CML were delineated. Seve ral 
recent studies have provided the evidence of the in-
creased risk of leukemia and other hematological 
malignancies in Chernobyl clean-up workers. In fact, 
a number of authors have predicted and reported 
the increased incidence of leukemia among clean-
up workers in Russia, Belarus and Ukraine [4, 10, 14], 
while the excess of leukemia was called in question 
elsewhere [7, 15].
A multinational case-control study of hematological 
malignancies among Chernobyl clean-up workers from 
Belarus, Russia and Baltic countries who had worked 
in Chernobyl in 1986–1987 provided by Kesminiene 
et al. [5] was one of the first such studies in which 
the individual dose reconstruction was attempted. 
RADRUE method of dose reconstruction developed 
for Chernobyl clean-up workers was used in this and 
subsequent studies [16]. 117 cases of malignancies 
of hematopoietic and lymphoid tissue (among them 
69 leukemias, 34 cases of non-Hodgkin’s lymphoma 
(NHL), 8 cases of multiple myeloma (MM), 2 MDS and 
4 cases of myeloproliferative disease, unclassifiable) 
were recorded in clean-up workers cohort with ERR 
per 10 cGy being of 0.60. Such risk estimates were 
slightly higher than that calculated from data obtained 
in studies with A-bomb survivors and other low dose-
rate studies. Among the malignancies in 70 clean-
up workers whose dose was estimated with RADRUE, 
CLL incidence was 30.0% and NHL — 28.6%.
198 cases of leukemias were reported in the Rus-
sian cohort of clean-up workers; among them 24.3% — 
all acute leukemias (without subdivision), 3.5% — 
MDS, 28.8% — CLL, 30.0% — CML combined with 
chronic myelomonocytic leukemia and several other 
forms of leukemias [10]. According to Ivanov et al., 
the dynamics of standardized incidence ratio demon-
strates a 2.5–3-fold increase in the leukemia incidence 
in the Russian cohort of Chernobyl clean-up work-
ers in 5–7 years after the accident [14]. According 
to the forecast presented by Tsyb et al. for the Russian 
cohort of clean-up workers of 1986–1987 with the aver-
age dose of 16 cGy, about 900 cases of leukemias are 
expected life-time with 18% of them being attributed 
to radiation exposure [17].
The data of a few studies analyzing leukemias 
in Ukrainian cohort of clean-up workers have been 
available. Prisyazhniuk et al. stated the statistically 
significant increment in observed-to-predicted ratio 
of leukemia and lymphoma incidence: 2.6 in 1990–
1993 and 2.0 in 1994–1997 [4]. In the report of Ukrai-
nian-American nested case-control study of the cohort 
of 110,645 clean-up workers from the Chernobyl State 
Registry of Ukraine, 87 leukemia cases confirmed 
by the International panel of hematologists were pre-
sented [18]. Among them — 49 (48.9%) cases of CLL, 
4 — ALL, 6 — AML, 9 cases of acute leukemia other-
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wise not specified, 15 — CML, and 4 cases of large 
granular lymphocytic leukemia (LGL). ERR of total 
leukemia was estimated as 3.44 per Gy.
Unfortunately, in most studies in post-soviet coun-
tries including Ukraine, the risks of increasing incidence 
of leukemias are based on the primary data categorized 
according to the obsolete ICD-9 (1975) classification 
where the acute leukemias have been registered in to-
tal without delineation of myeloid and lymphoid forms 
as well as cytological and immunophenotypic variants. 
Moreover, until recently only cytomorphology and se-
veral cytochemical techniques were routinely used for 
the diagnostic purposes in oncohematology in the vast 
majority of the hematological clinics in Ukraine.
PATTERNS OF MALIGNANT 
DISEASES OF HEMATOPOIETIC 
AND LYMPHOID TISSUES IN UKRAINIAN 
CLEAN-UP WORKERS
Precise diagnosis of the different types of hema-
tological malignancies based on up-to-date clas-
sifications taking into account cytomorphological, 
immunophenotypical and molecular genetic features 
has contributed largely to our insight into radiation-
induced leukemogenesis. The origin of one or another 
biological subtypes and cytological variants of leuke-
mia seems to be specified by the effects of ionizing 
radiation on the pluripotent hematopoietic stem cells 
or the various categories of hematopoietic progenitor 
cells. Therefore, the comparative analysis of the pat-
terns of oncohematological pathologies developed 
many years following the exposure of ionizing radiation 
in large cohorts of exposed persons is a topical issue 
of studies in Japanese A-bomb survivors, in Cher-
nobyl clean-up workers and in residents of the areas 
contaminated with radionuclides as a consequence 
of Chernobyl disaster.
In 1993, the Reference Laboratory was set 
up as a public service at R.E. Kavetsky Institute 
of Experimental Pathology, Oncology and Radiobio-
logy of the National Academy of Sciences of Ukraine 
with the aim of the precise diagnosis of the hema-
topoietic malignancies based on cytomorphology, 
cytoche mistry, immunophenotyping in accordance with 
FAB, WHO, EGIL, ICD-10 and ICD-0–4 classifications. 
One of the principal tasks of the Reference Labora-
tory consisted in the systematic study of the malignant 
diseases of hematopoietic and lymphoid tissues in the 
major categories of people suffered due to Chernobyl 
catastrophe.
Since 1996, about 450 Ukrainian Chernobyl clean-
up workers from Kyiv city and majority of the regional 
hospitals of Ukraine with suspected oncohemato-
logical disorders were referred to Reference Labora-
tory for confirmation and verification of the diagnosis. 
In 1996–2010, 295 cases of various types of leukemia 
were diagnosed and categorized in this group ac-
cording to up-to-date classifications. In addition, 
in 118 patients among Chernobyl clean-up workers 
referred to Reference Laboratory non-malignant 
hematological diseases (aplastic anemia, hemolytic 
anemia, idiopathic thrombocytopenia, neutrophylic 
leukocytosis, lymphocytosis, dysgranulocytopoiesis, 
etc.) were ascertained. The year-by-year number 
of leukemia patients among Chernobyl clean-up wor-
kers first diagnosed in the Reference Laboratory is re-
presented in Fig. 1. As shown in Fig. 2, more than half 
of the patients in this group were diagnosed at the age 
above 60. All of them have been exposed to radiation 
in the course of emergency works at the age of 25–40. 
While the exact individual dosimetry data were lacking 
in most cases (as in most other Chernobyl studies), 
the estimated radiation dose load of the clean-up wor-
kers under study varied from 75 to 250 mGy. The main 
forms and cytological variants of hematological malig-
nancies were diagnosed according to FAB-classifica-
tion and REAL classification schemes. In 2001–2010, 
the diagnostic findings were revised in accordance with 
recently published new WHO classification of tumors 
of hematopoietic and lymphoid tissues [19].
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Fig. 1. Number of leukemia patients among clean-up workers 
first diagnosed in the Reference Laboratory in 1996–2010
4.2%
13.7%
31.2%
38.3%
12.6%
30–39 40–49 50–59
60–69 70 and above
Fig. 2. Age distribution of leukemia patients among clean-
up workers diagnosed in the Reference Laboratory in 1996–2010
The data on leukemia among Ukrainian Cher-
nobyl clean-up workers diagnosed in 1996–2010 (10–
25 years after Chernobyl catastrophe) were compared 
with the data on 2697 consecutive patients referred 
to the laboratory for diagnosing from various regions 
of Ukraine within the same period without any selection 
of cases. The data on the phenotypes of leukemias 
in the group of clean-up workers and the patients who 
have not been explicitly exposed to ionizing radiation 
as well as the comparison of the percentage of the vari-
ous biological types of leukemia in both groups are 
given elsewhere [20].
All the main types of tumors of hematopoietic and 
lymphoid tissues including B-CLL have been diag-
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nosed. The summary of all leukemia cases diagnosed 
among Chernobyl clean-up workers (295 cases) are 
given in Table together with the most recent data 
on leukemia patterns among LSS cohort (1215 cases 
in total) [3]. The general distribution of different 
biological subtypes of leukemia in Chernobyl clean-
up workers and patients in LSS is quite similar.
Table. Absolute numbers and percentage of the major forms of tumors of hema-
topoietic and lymphoid tissues registered in cohort of LSS study up to 55 years 
after exposure [3] and in Chernobyl clean-up workers according to the files 
of Reference Laboratory in 10–25 years after exposure [20]
Types of hematological malignancies LSS, n (%) Clean-up workers, n (%)
AML 229 (18.85) 46 (15.60)
ALL 62 (5.10) 17 (5.76)
Other leukemias including acute leukemia 
not otherwise specified 26 (2.14) −
CML 99 (8.15) 27 (9.15)
Other myeloproliferative neoplasms − 23 (7.79)
Chronic myelomonocytic leukemia − 10 (3.39)
MDS − 16 (5.42)
CLL 16 (1.32) 77 (26.10)
NHL 501 (41.23) 35 (11.86)
Hodgkin’s lymphoma 42 (3.46) −
MM 181 (14.90) 19 (6.46)
Other mature B-cell neoplasms − 15 (5.08)
Mature T-cell neoplasms (including T-cell 
LGL leukemia) − 10 (3.39)
Adult T-cell leukemia 59 (4.85) −
Total 1215 295
When calculated cumulatively, the total percentage 
of three major forms of leukemias thought to be radi-
ation-associated, namely ALL, AML, and CML, is simi-
lar in patients of LSS cohort and Chernobyl clean-
up worker patients under the present study (32.10% 
and 30.51%, respectively) (see Table). Several 
discrepancies are quite obvious due to the different 
purposes and designs of these studies.
MDS has not been specially delineated in LSS [3], 
while this entity is believed to be associated with 
radiation in other studies based on LSS and ABDI 
cohorts [21]. MDS risk showed a significant linear 
response to exposure dose being also significantly 
greater in those exposed when young [22]. Moreover, 
ac cording to Iwanaga et al., 42 of 151 MDS patients 
under follow-up study progressed to overt leukemia 
[21]. In our study, in the group of clean-up workers 
the morphological features of myelodysplasia were 
detected in 7 (15.2%) of 46 patients with various cy-
tological variants of AML, while in AML patients among 
non-exposed population of Kyiv city and Kyiv region 
such features of myelodysplasia were found only 
in 1.5% of all AML cases. This suggests that in the pa-
tients exposed to ionizing radiation the overt AML more 
frequently develops in the setting of preceding MDS 
[20]. Further studies are needed to clarify whether 
MDS is in fact associated with exposure to radiation 
taking into account gross underestimation of these 
pathologies in Ukraine. Much longer follow-up seems 
to be required for a correct estimate of radiation-
associated risks of MDS and its conversion into overt 
acute leukemia.
Recent epidemiological data suggest the possible 
association between radiation exposure and CLL [5, 
23]. These novel data contradict the previous ones 
including those in LSS [3, 6]. Evaluation of CLL radio-
genicity is hampered by a priori exclusion of CLL from 
many analyses reasoning that in other studies CLL has 
not been proved as radiation-associated leukemia [24]. 
It should be also taken into account that the classic LSS 
analyses are based on Japanese population wherein 
CLL is rather rare form of leukemia, while in USA and Eu-
rope B-CLL represents one of the most prevalent forms 
of leukemia in adults. The relatively low per centage 
of NHL in our study [20] is explained by the fact that 
only NHL cases in leukemization phase have been re-
corded in Reference Laboratory. In our previous study, 
we have demonstrated the tendency for increased 
MM rate among leukemias originating in Chernobyl 
clean-up workers [20]. The trend of the increased 
MM incidence was observed in epidemiological study 
in the contaminated areas of Belarus [25]. While earlier 
LSS data presented the evidence for increased MM risk 
among exposed persons [26], further LSS studies have 
not confirmed radiogenicity of MM [3]. Since MM, 
like CLL, is a malignant proliferative disorder of B-cell 
line age, the novel data on CLL radiogenicity require 
the thorough consideration of MM rate among exposed 
persons in different populations.
The high incidence of LGL-leukemia among clean-
up workers with hematopoietic malignancies (1.69% 
vs 0,11% in non-exposed population [20]) is of particu-
lar importance since this category of T-cell and NK-cell 
neoplasms has not been revealed earlier in Ukraine. 
High incidence of neutropenia due to NK or NK-like 
T-cell proliferative disorders was found among atomic 
bomb survivors in Japan [27].
To sum up, the studies in populations of Hiroshima 
and Nagasaki victims and Chernobyl clean-up wor kers 
revealed very broad spectrum of radiation-related 
hematological malignancies despite the differences 
among the types of exposure, dose rate, differences 
in age-sex structure of the exposed populations, 
etc. The following epidemiological surveys should 
be supplemented with studies based on molecular 
biology including the search for the specific radio-
genic markers in leukemic cells. Moreover, the data 
on the tumors of hematopoietic and lymphoid tissues 
in the exposed persons after Chernobyl catastrophe 
may be very important for the prognostic estimates 
of the health effects of the Fukushima disaster.
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